New ERAMET Publication: Advancing the frontier of rare disease modeling: a critical appraisal of in silico technologies

“Advancing the frontier of rare disease modeling: a critical appraisal of in silico technologies” is ERAMET's newest publication appearing in Nature Digital Medicine. This new article published on 17th November,…

Continue ReadingNew ERAMET Publication: Advancing the frontier of rare disease modeling: a critical appraisal of in silico technologies

XVII Foresight training Course | From research to access: how does Europe speed up the availability of medicines for unmet needs? | 3-4 November | Online

ERAMET Project partner, Fondazione per la ricerca Farmacologica Gianni Benzi Onlus, will host the XVII edition of the Foresight Training Course, titled “From research to access: how does Europe speed…

Continue ReadingXVII Foresight training Course | From research to access: how does Europe speed up the availability of medicines for unmet needs? | 3-4 November | Online

ERAMET at PAGE 2025 in Thessaloniki: Advancing Model-Informed Drug Development in Paediatrics and Rare Diseases

ERAMET was proud to participate in PAGE 2025, held from June 3–6 at the Thessaloniki Concert Hall, where experts from across academia, regulatory agencies, and industry gathered to share and debate the latest in…

Continue ReadingERAMET at PAGE 2025 in Thessaloniki: Advancing Model-Informed Drug Development in Paediatrics and Rare Diseases

New ERAMET Publication: AI-Driven Applications in Clinical Pharmacology and Translational Science

A new article has been published in Clinical and Translational Science, titled: AI-Driven Applications in Clinical Pharmacology and Translational Science: Insights From the ASCPT 2024 AI PreconferenceThe publication summarises key…

Continue ReadingNew ERAMET Publication: AI-Driven Applications in Clinical Pharmacology and Translational Science